vs
Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $183.6M, roughly 1.9× ACV Auctions Inc.). On growth, ACV Auctions Inc. posted the faster year-over-year revenue change (15.1% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $-14.7M). Over the past eight quarters, ACV Auctions Inc.'s revenue compounded faster (12.3% CAGR vs 1.5%).
ACV Auctions Inc.ACVAEarnings & Financial Report
ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ACVA vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $183.6M | $346.4M |
| Net Profit | — | $97.3M |
| Gross Margin | — | 57.2% |
| Operating Margin | -9.7% | 36.1% |
| Net Margin | — | 28.1% |
| Revenue YoY | 15.1% | 4.8% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | $183.6M | $339.0M | ||
| Q3 25 | $199.6M | $327.3M | ||
| Q2 25 | $193.7M | $321.4M | ||
| Q1 25 | $182.7M | $330.6M | ||
| Q4 24 | $159.5M | $348.5M | ||
| Q3 24 | $171.3M | $345.5M | ||
| Q2 24 | $160.6M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | — | $44.7M | ||
| Q3 25 | $-24.5M | $38.7M | ||
| Q2 25 | $-7.3M | $34.0M | ||
| Q1 25 | $-14.8M | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $-16.0M | $33.8M | ||
| Q2 24 | $-17.1M | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | -9.7% | 19.9% | ||
| Q3 25 | -11.9% | 17.9% | ||
| Q2 25 | -3.7% | 16.8% | ||
| Q1 25 | -7.9% | 21.6% | ||
| Q4 24 | -16.2% | 16.9% | ||
| Q3 24 | -10.0% | 15.0% | ||
| Q2 24 | -11.6% | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | — | 13.2% | ||
| Q3 25 | -12.3% | 11.8% | ||
| Q2 25 | -3.8% | 10.6% | ||
| Q1 25 | -8.1% | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -9.4% | 9.8% | ||
| Q2 24 | -10.6% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.12 | $0.95 | ||
| Q3 25 | $-0.14 | $0.81 | ||
| Q2 25 | $-0.04 | $0.70 | ||
| Q1 25 | $-0.09 | $1.17 | ||
| Q4 24 | $-0.15 | $0.74 | ||
| Q3 24 | $-0.10 | $0.66 | ||
| Q2 24 | $-0.10 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $271.5M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $429.7M | $796.3M |
| Total Assets | $1.1B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $271.5M | $363.4M | ||
| Q3 25 | $265.3M | $296.4M | ||
| Q2 25 | $258.4M | $292.9M | ||
| Q1 25 | $291.9M | $306.8M | ||
| Q4 24 | $224.1M | $320.8M | ||
| Q3 24 | $252.5M | $299.3M | ||
| Q2 24 | $215.0M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $429.7M | $911.5M | ||
| Q3 25 | $434.4M | $849.2M | ||
| Q2 25 | $448.8M | $882.3M | ||
| Q1 25 | $439.6M | $820.8M | ||
| Q4 24 | $440.0M | $906.9M | ||
| Q3 24 | $456.2M | $878.9M | ||
| Q2 24 | $457.6M | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.2B | $2.4B | ||
| Q2 25 | $1.1B | $2.5B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $984.1M | $2.5B | ||
| Q3 24 | $1.0B | $2.5B | ||
| Q2 24 | $1.0B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-12.4M | $293.2M |
| Free Cash FlowOCF − Capex | $-14.7M | $209.9M |
| FCF MarginFCF / Revenue | -8.0% | 60.6% |
| Capex IntensityCapex / Revenue | 1.2% | 9.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $69.1M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $-12.4M | $93.6M | ||
| Q3 25 | $10.3M | $111.3M | ||
| Q2 25 | $13.7M | $17.4M | ||
| Q1 25 | $66.6M | $116.6M | ||
| Q4 24 | $-3.2M | $43.8M | ||
| Q3 24 | $21.1M | $48.8M | ||
| Q2 24 | $4.5M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $-14.7M | $87.2M | ||
| Q3 25 | $7.7M | $106.3M | ||
| Q2 25 | $10.9M | $13.6M | ||
| Q1 25 | $65.3M | $100.9M | ||
| Q4 24 | $-3.9M | $35.2M | ||
| Q3 24 | $20.2M | $39.4M | ||
| Q2 24 | $2.7M | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | -8.0% | 25.7% | ||
| Q3 25 | 3.8% | 32.5% | ||
| Q2 25 | 5.6% | 4.2% | ||
| Q1 25 | 35.7% | 30.5% | ||
| Q4 24 | -2.5% | 10.1% | ||
| Q3 24 | 11.8% | 11.4% | ||
| Q2 24 | 1.7% | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | 1.2% | 1.9% | ||
| Q3 25 | 1.3% | 1.5% | ||
| Q2 25 | 1.5% | 1.2% | ||
| Q1 25 | 0.7% | 4.7% | ||
| Q4 24 | 0.4% | 2.5% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 1.1% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
